A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

Completed · Phase 3

Conditions studied: Type 2 Diabetes

In brief

Phase 3 study to compare treatment with ITCA 650 to sitagliptin when added to metformin monotherapy in patients with type 2 diabetes.

Key facts

Study ID

NCT01455870

Run by

Intarcia Therapeutics

People needed

535

Starts

2013-05-01

Expected to finish

2015-07-01

Last updated by the study team

2016-06-02

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HbA1c between 7.5% - 10.5%
• on metformin monotherapy
• BMI between 25 \& 45 kg/m2

You may not qualify if…

• taking thiazolidinedione, sulfonylurea, DPP-4, exenatide, alpha glucosidase inhibitors, meglitinides or insulin within last 3 months
• history of pancreatitis

Where it is running

• Study site — Chandler, Arizona, United States
• Study site — Long Beach, California, United States
• Study site — Los Angeles, California, United States
• Study site — San Diego, California, United States
• Study site — San Mateo, California, United States
• Study site — Tustin, California, United States
• Study site — Valley Village, California, United States
• Study site — Walnut Creek, California, United States
• Study site — Boca Raton, Florida, United States
• Study site — Clearwater, Florida, United States
• Study site — Coral Gables, Florida, United States
• Study site — Miami, Florida, United States
• Study site — North Miami Beach, Florida, United States
• Study site — Pembroke Pines, Florida, United States
• Study site — Canton, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Chicago, Illinois, United States
• Study site — Avon, Indiana, United States
• Study site — Franklin, Indiana, United States
• Study site — Greenfield, Indiana, United States
• Study site — Muncie, Indiana, United States
• Study site — Valparaiso, Indiana, United States
• Study site — Wichita, Kansas, United States
• Study site — Wichita, Kansas, United States
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.